ono-8539
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2009 (NCT00876421)
Timeline
Indications
Mechanism of action
- Prostanoid EP1 receptorANTAGONIST
PTGER1 antagonist
Chemistry & pharmacology
Loading structure…
SMILES
Cc1cc(C(=O)O)ccc1COc1cc2c(cc1N(CC(C)C)S(=O)(=O)c1nccs1)CCC2- Mol. weight
- 500.64 g/mol
- Lipinski Ro5
- 2 violation(s)
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3912251 ↗
Also known as
- ono-8539
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01705275 | Phase 1 | Jan 1, 2013 | Ono Pharmaceuticals |
| NCT01707901 | Phase 1 | Dec 1, 2012 | Ono Pharmaceuticals |
| NCT00876421 | Phase 2 | Apr 1, 2009 | Ono Pharmaceuticals |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ono Pharmaceuticals | For profit | 3 | 3 | 2 | 2009 |
1 organizations
Page 1 / 1